+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vifor Pharma - logo

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

Hyperphosphatemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hyperphosphatemia Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 101 Pages
  • Global
From
Taste Masking and Taste Assessment Services and Technologies Market, Distribution by Type of Formulation, Type of Techniques, Scale of Operation and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Taste Masking and Taste Assessment Services and Technologies Market, Distribution by Type of Formulation, Type of Techniques, Scale of Operation and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • June 2022
  • 200 Pages
  • Global
From
Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Chronic Kidney Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • November 2018
  • 164 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Global Iron Drugs Market 2024-2028 - Product Thumbnail Image

Global Iron Drugs Market 2024-2028

  • Report
  • June 2024
  • 174 Pages
  • Global
From
End Stage Renal Disease (ESRD) Drug Global Market Report 2024 - Product Thumbnail Image

End Stage Renal Disease (ESRD) Drug Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Late Stage Chronic Kidney Disease Drugs Global Market Report 2024 - Product Thumbnail Image

Late Stage Chronic Kidney Disease Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Nephrology Drugs Global Market Report 2024 - Product Thumbnail Image

Nephrology Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 277 Pages
  • Global
From
Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Thalassemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 156 Pages
  • Global
From
Hemochromatosis (Iron Overload) Disease Treatment Global Market Report 2024 - Product Thumbnail Image

Hemochromatosis (Iron Overload) Disease Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Renal Anemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Renal Anemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 201 Pages
  • Global
Anemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Anemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Anemia And Other Blood Disorder Drugs Global Market Report 2024 - Product Thumbnail Image

Anemia And Other Blood Disorder Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Sickle Cell Disease Treatment Market By Drug Type, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Sickle Cell Disease Treatment Market By Drug Type, By Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 292 Pages
  • Global
From
Beta-thalassemia - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-thalassemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
IgA Nephropathy (IgAN) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

IgA Nephropathy (IgAN) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 195 Pages
  • Global
From
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 218 Pages
  • Global
From
Global IgA Nephropathy Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global IgA Nephropathy Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 259 Pages
  • Global
From
Loading Indicator